These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33252728)

  • 1. Factor VIII and Factor V Membrane Bound Complexes.
    Stoilova-McPhie S
    Subcell Biochem; 2021; 96():153-175. PubMed ID: 33252728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
    Koklic T; Chattopadhyay R; Majumder R; Lentz BR
    Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of clotting factors.
    Kalafatis M; Egan JO; van 't Veer C; Cawthern KM; Mann KG
    Crit Rev Eukaryot Gene Expr; 1997; 7(3):241-80. PubMed ID: 9399073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of factor V and VIII procofactor activation.
    Camire RM; Bos MH
    J Thromb Haemost; 2009 Dec; 7(12):1951-61. PubMed ID: 19765210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
    Nogami K; Shima M; Nishiya K; Hosokawa K; Saenko EL; Giddings JC; Tanaka I; Yoshioka A
    Br J Haematol; 2002 Mar; 116(4):868-74. PubMed ID: 11886394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.
    Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA
    Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
    Dahlbäck B
    J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V and thrombotic disease: description of a janus-faced protein.
    Nicolaes GA; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
    Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
    Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
    Koshiar RL; Somajo S; Norström E; Dahlbäck B
    PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.
    Slatter DA; Percy CL; Allen-Redpath K; Gajsiewicz JM; Brooks NJ; Clayton A; Tyrrell VJ; Rosas M; Lauder SN; Watson A; Dul M; Garcia-Diaz Y; Aldrovandi M; Heurich M; Hall J; Morrissey JH; Lacroix-Desmazes S; Delignat S; Jenkins PV; Collins PW; O'Donnell VB
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
    Steen M; Villoutreix BO; Norstrøm EA; Yamazaki T; Dahlbäck B
    J Biol Chem; 2002 Dec; 277(51):50022-9. PubMed ID: 12384508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane-mediated coagulation protease complex assembly.
    Ahmad SS; Walsh PN
    Trends Cardiovasc Med; 1994; 4(6):271-8. PubMed ID: 21244878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells.
    Fernandes RS; Kirszberg C; Rumjanek VM; Monteiro RQ
    J Thromb Haemost; 2006 Jul; 4(7):1546-52. PubMed ID: 16839352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation.
    Abrams ST; Su D; Sahraoui Y; Lin Z; Cheng Z; Nesbitt K; Alhamdi Y; Harrasser M; Du M; Foley JH; Lillicrap D; Wang G; Toh CH
    Blood; 2021 Jan; 137(1):103-114. PubMed ID: 33410894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.
    Pieters J; Lindhout T; Hemker HC
    Blood; 1989 Aug; 74(3):1021-4. PubMed ID: 2502206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
    J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII organisation on nanodiscs with different lipid composition.
    Grushin K; Miller J; Dalm D; Stoilova-McPhie S
    Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.